Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 101401-101450 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04432597
HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers
PHASE1/PHASE2
Active, not recruiting
39 participants
Started: Aug 11, 2020 · Completed: Nov 20, 2025
5 conditions
1 sponsor
1 location
NCT04162496
Restylane Refyne for Correction of Horizontal Neck Rhytides
NA
Active, not recruiting
24 participants
Started: Aug 11, 2020 · Completed: Sep 30, 2021
3 conditions
2 sponsors
1 location
NCT04362527
Milrinone Infusion for VAsospam Treatment in Subarachnoid hemoRrhage
PHASE3
Recruiting
370 participants
Started: Aug 10, 2020 · Completed: Jan 11, 2026
1 condition
1 sponsor
16 locations
NCT04503551
A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm
PHASE3
Active, not recruiting
174 participants
Started: Aug 10, 2020 · Completed: Jun 13, 2025
1 condition
1 sponsor
64 locations
NCT04501536
Determining Optimal Treatment Intensity for Children With Language Impairment
NA
Active, not recruiting
59 participants
Started: Aug 10, 2020 · Completed: Jul 31, 2025
1 condition
2 sponsors
2 locations
NCT04074382
FIT Study (Functional Outcomes In Trauma Study)
N/A
Active, not recruiting
440 participants
Started: Aug 10, 2020 · Completed: Sep 30, 2032
11 conditions
1 sponsor
1 location
NCT04274179
Ketogenic Diet for New-Onset Absence Epilepsy
PHASE3
Recruiting
40 participants
Started: Aug 10, 2020 · Completed: May 1, 2026
3 conditions
1 sponsor
1 location
NCT04482374
Puberty Suppression and Cardiometabolic Health
N/A
Recruiting
30 participants
Started: Aug 10, 2020 · Completed: Jul 31, 2026
4 conditions
1 sponsor
1 location
NCT04808596
Pulmonary Hypertension Biorepository and Registry
N/A
Recruiting
300 participants
Started: Aug 10, 2020 · Completed: Jul 31, 2027
9 conditions
1 sponsor
1 location
NCT04267588
Using Technology to Track Pain and Pain-related Outcomes
N/A
Recruiting
100 participants
Started: Aug 10, 2020 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT04469517
Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia
N/A
Recruiting
100 participants
Started: Aug 10, 2020 · Completed: Oct 1, 2026
1 condition
1 sponsor
1 location
NCT06840262
Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation
NA
Recruiting
45 participants
Started: Aug 10, 2020 · Completed: Feb 2, 2027
1 condition
1 sponsor
1 location
NCT04333576
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain
PHASE3
Recruiting
800 participants
Started: Aug 10, 2020 · Completed: Jun 30, 2030
1 condition
1 sponsor
179 locations
NCT04204499
Analysis of Screen-detected Lung Cancers' Genomic Traits
N/A
Recruiting
526 participants
Started: Aug 10, 2020 · Completed: Mar 30, 2026
1 condition
1 sponsor
2 locations
NCT04858958
Study of FURMONERTINIB in Patients With NSCLC Having Exon 20 Insertion Mutation
PHASE1
Active, not recruiting
30 participants
Started: Aug 10, 2020 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT03764098
Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders
PHASE2
Recruiting
160 participants
Started: Aug 10, 2020 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT04176848
CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer
PHASE2
Active, not recruiting
15 participants
Started: Aug 10, 2020 · Completed: Dec 31, 2025
1 condition
3 sponsors
5 locations
NCT04221477
A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis
PHASE3
Active, not recruiting
271 participants
Started: Aug 10, 2020 · Completed: Feb 28, 2028
1 condition
1 sponsor
73 locations
NCT06083649
The Dental Care Revolution: Health Education Using AI or Humanized Counseling on Plague Control and Periodontal Treatment Outcome in Patients With Periodontal Disease
NA
Recruiting
100 participants
Started: Aug 10, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04510740
Liver Cancer Registry Platform
N/A
Recruiting
1,000 participants
Started: Aug 9, 2020 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT04466852
Brazilian Heart Insufficiency With Telemedicine
NA
Recruiting
720 participants
Started: Aug 8, 2020 · Completed: Dec 31, 2025
1 condition
4 sponsors
2 locations
NCT04204850
Cabozantinib to Treat Recurrent Liver Cancer Post Transplant
PHASE2
Recruiting
20 participants
Started: Aug 7, 2020 · Completed: Dec 7, 2025
3 conditions
2 sponsors
1 location
NCT04304625
TRAnexamic Acid for Preventing Blood Loss Following a Cesarean Delivery in Women With Placenta pREVIA
PHASE3
Recruiting
1,380 participants
Started: Aug 7, 2020 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT05376241
Promoting Informed Choice for Breast Cancer Screening
N/A
Active, not recruiting
498 participants
Started: Aug 7, 2020 · Completed: May 31, 2025
1 condition
2 sponsors
1 location
NCT04169763
Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery
PHASE1
Recruiting
25 participants
Started: Aug 7, 2020 · Completed: Dec 31, 2026
6 conditions
2 sponsors
1 location
NCT04221893
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
NA
Recruiting
28 participants
Started: Aug 7, 2020 · Completed: Apr 30, 2028
44 conditions
2 sponsors
2 locations
NCT04246333
Duodenal Feeds in Very Low Birth Weight Infants
NA
Recruiting
30 participants
Started: Aug 7, 2020 · Completed: Mar 31, 2026
6 conditions
1 sponsor
1 location
NCT04416269
Oral Anti Diabetic Agents in the Hospital
PHASE4
Recruiting
260 participants
Started: Aug 7, 2020 · Completed: May 31, 2026
1 condition
2 sponsors
3 locations
NCT04472767
Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma
PHASE2
Recruiting
35 participants
Started: Aug 7, 2020 · Completed: Sep 1, 2027
2 conditions
2 sponsors
1 location
NCT04395079
Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies
PHASE2
Active, not recruiting
9 participants
Started: Aug 7, 2020 · Completed: Dec 1, 2026
4 conditions
2 sponsors
1 location
NCT04513483
CPAP in AF Patients With OSA
NA
Active, not recruiting
100 participants
Started: Aug 7, 2020 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT04946279
Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung Cancer
NA
Active, not recruiting
98 participants
Started: Aug 7, 2020 · Completed: Dec 31, 2026
5 conditions
5 sponsors
2 locations
NCT04227847
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
PHASE1
Recruiting
178 participants
Started: Aug 7, 2020 · Completed: Jul 3, 2028
2 conditions
1 sponsor
54 locations
NCT04776941
Expressive Writing for the Management of Stress in Cancer Survivors
NA
Recruiting
414 participants
Started: Aug 7, 2020 · Completed: Dec 31, 2028
2 conditions
2 sponsors
1 location
NCT04856501
A Randomized Control Trial of a Responsive Parenting Intervention to Support Healthy Brain Development and Self-regulation in Toddlers Born Preterm
NA
Recruiting
300 participants
Started: Aug 7, 2020 · Completed: Jun 30, 2025
1 condition
3 sponsors
1 location
NCT04703699
Myval Global Study of Myval™ THV Series Implanted in Patients With Native Severe Aortic Valve Stenosis.
N/A
Recruiting
200 participants
Started: Aug 7, 2020 · Completed: Nov 30, 2028
1 condition
1 sponsor
8 locations
NCT04189757
Acalabrutinib for the Treatment of Ibrutinib-Intolerant Mantle Cell Lymphoma
PHASE2
Active, not recruiting
9 participants
Started: Aug 7, 2020 · Completed: Jun 30, 2027
1 condition
2 sponsors
1 location
NCT04514029
Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel
EARLY_PHASE1
Active, not recruiting
37 participants
Started: Aug 6, 2020 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03146546
STUDY00015328: Sepsis Endotypes
N/A
Enrolling by invitation
200 participants
Started: Aug 6, 2020 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT04240756
Treating Parents with ADHD and Their Young Children Via Telehealth: a Hybrid Type I Effectiveness-Implementation Trial
PHASE3
Active, not recruiting
240 participants
Started: Aug 6, 2020 · Completed: Jul 31, 2025
2 conditions
5 sponsors
1 location
NCT04430192
Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy
PHASE1/PHASE2
Active, not recruiting
20 participants
Started: Aug 6, 2020 · Completed: Aug 30, 2025
1 condition
5 sponsors
1 location
NCT04432285
Long-term Outcome of DBS Versus Botulinum Toxin Treatment in Cervical Dystonia
N/A
Enrolling by invitation
50 participants
Started: Aug 6, 2020 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04195451
Re-Energize Fontan
NA
Recruiting
150 participants
Started: Aug 6, 2020 · Completed: Mar 1, 2026
1 condition
3 sponsors
1 location
NCT05334290
Financial Toxicity and Patient-Reported Outcomes in GEP-NEN During Treatment
N/A
Recruiting
400 participants
Started: Aug 6, 2020 · Completed: Aug 5, 2024
1 condition
1 sponsor
1 location
NCT04341350
Comparison of an Inhaled Sedation Strategy to an Intravenous Sedation Strategy in Intensive Care Unit Patients Treated With Invasive Mechanical Ventilation
PHASE3
Recruiting
250 participants
Started: Aug 6, 2020 · Completed: Aug 31, 2026
1 condition
1 sponsor
12 locations
NCT05200715
AutoInflammatory Disease Alliance Registry (AIDA)
N/A
Recruiting
3,500 participants
Started: Aug 6, 2020 · Completed: Aug 6, 2030
11 conditions
1 sponsor
112 locations
NCT04300556
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
PHASE1/PHASE2
Recruiting
182 participants
Started: Aug 6, 2020 · Completed: Aug 8, 2030
1 condition
1 sponsor
58 locations
NCT04356729
A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma
PHASE2
Active, not recruiting
30 participants
Started: Aug 6, 2020 · Completed: Sep 1, 2026
4 conditions
2 sponsors
3 locations
NCT04477629
Belatacept in De Novo Heart Transplantation
PHASE2
Recruiting
12 participants
Started: Aug 6, 2020 · Completed: Sep 30, 2026
1 condition
2 sponsors
2 locations
NCT04079712
Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors
PHASE2
Active, not recruiting
17 participants
Started: Aug 6, 2020 · Completed: Jul 14, 2026
4 conditions
1 sponsor
46 locations
Previous
1
More pages
2026
2027
2028
2029
2030
2031
2032
More pages
2369
Next